Docoh
Loading...

AGN Allergan

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands andbest-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology. As part of its approach to delivering innovation for better patient care, Allergan has built one of the broadest pharmaceutical and device research and development pipelines in the industry.

Company profile

Ticker
AGN
Exchange
CEO
Brenton L. Saunders
Employees
Incorporated
Location
Fiscal year end
Former names
Actavis Ltd, Actavis plc
SEC CIK

AGN stock data

(
)

Calendar

7 May 20
28 Feb 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D No No 0 16,532 0 0
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D Yes No 0 9,538 0 16,542
8 May 20 Coughlin Christopher J Ordinary Shares, par value $0.0001 Sale back to company Dispose D Yes No 0 471 0 26,080
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 70.79 9,446 668.68K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 73.14 3,691 269.96K 0
8 May 20 Coughlin Christopher J Stock Options Ordinary Shares Sale back to company Dispose D No No 90.22 2,790 251.71K 0
8 May 20 William Meury RSU Sale back to company Dispose D No No 0 25,201 0 0
8 May 20 William Meury Ordinary Shares, par value $0.0001 Sale back to company Dispose D No No 0 7,434 0 0
8 May 20 William Meury Performance Stock Units Ordinary Shares Sale back to company Dispose D No No 0 26,506 0 0
8 May 20 William Meury Stock Options Ordinary Shares Sale back to company Dispose D No No 196.16 12,304 2.41M 0
0.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 3 5 -40.0%
Opened positions 2 2
Closed positions 4 6 -33.3%
Increased positions 0 0
Reduced positions 0 1 EXIT
13F shares
Current Prev Q Change
Total value 3.06M 21.89M -86.0%
Total shares 17.31K 222.32K -92.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
TMP Tompkins Financial 17.04K $3.02M NEW
Founders Capital Management 276 $46K NEW
IFP Advisors 0 $0
Largest transactions
Shares Bought/sold Change
Ashburton 0 -195.5K EXIT
New Mexico Educational Retirement Board 0 -23.73K EXIT
TMP Tompkins Financial 17.04K +17.04K NEW
Belpointe Asset Management 0 -2.34K EXIT
JDC-JSC 0 -750 EXIT
Founders Capital Management 276 +276 NEW
IFP Advisors 0 0

Financial report summary

?
Competition
AkornTherapeuticsMDAMGENHologicVeruVivusRoyalty PharmaPalatinIntegra LifesciencesIRIDEX
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: alpha, API, argument, Asia, AstraZeneca, autoimmune, behavior, biodegradable, broadest, built, buyer, Cadila, certainty, chain, composition, confirm, confirming, contamination, continent, Coolsculpting, CoolTone, Cream, cystic, declare, deliver, detailing, discontinuation, discontinued, distancing, Durysta, electronic, enrolling, environment, enzyme, Esthetique, evolve, exocrine, experienced, Gedeon, genericization, glaucoma, globe, half, home, hypertension, inability, indirectly, inhibitor, innovation, insufficiency, intracameral, intraocular, IOP, Ireland, Lab, Lazeo, LIBOR, lifetime, local, logistical, losing, medial, minute, mitigate, Nestle, OAG, ocular, OHT, outbreak, Pacific, pancreatic, pandemic, patient, pressure, rebate, recession, recovery, relationship, remotely, reply, Richter, satisfaction, Science, shelter, spent, spread, strain, susceptible, suspended, temporarily, Ubrelvy, unemployment, Viokace, Vital
Removed: absence, acceleration, acid, add, adjunctive, advancement, affirming, Akorn, Akron, Apotex, appellate, applied, Argentum, asserting, authorize, automatically, back, binding, BioMed, Biomedical, Body, bound, buy, calculate, calculated, capitalized, capitalizing, Center, centralized, certiorari, chosen, clarify, cloud, collateralization, collateralized, commonly, computing, concurrently, Contouring, contractually, conversion, correct, corrected, Corrupt, cumulative, delaying, Delzicol, denial, denying, Depressive, dermatology, determining, Deva, disgorgement, Disorder, dozen, Easement, enablement, enacted, enforceable, Envy, equaled, equipment, equitable, error, established, estate, Europe, exemption, exercised, expedient, explicitly, Famy, fiscal, fleet, fourth, Framework, gamma, GILTI, ground, Harbor, HD, higher, hosted, immunity, implementation, implicit, implicitly, improper, incorrectly, India, Influenced, InnoPharma, institute, instrument, intent, invalidity, inventorship, issuing, joinder, LA, land, lease, leasing, Legacy, legally, lessee, lessor, Lidoderm, LifeCell, limit, Low, mandatorily, mandatory, MDD, modified, modify, noncancelable, notification, offsetting, older, opening, option, orphan, ownership, package, pattern, Pennsylvania, pension, permission, pertaining, Pharmacal, pivotal, plant, Plastic, postretirement, practical, preferred, prepaid, preventing, privately, pronouncement, prospectively, purpose, qualify, Racketeer, rapastinel, rating, reaching, real, receptor, reclassification, reclassify, recognition, redeemed, refinancing, released, remove, renew, renewal, rental, Replacement, represented, requiring, residual, restitution, resurfacing, retinoic, retired, retrospective, retrospectively, revaluation, reversing, RORyt, ROU, SA, scaling, shortened, skin, Slayback, software, sovereign, standalone, statutory, stranded, substantive, substitute, Subtopic, suit, supplier, Surgery, suspension, Targeted, Taxed, TCJA, terminate, Therapy, threshold, topline, treble, tribal, TWi, Ubrogepant, unrelated, updated, USD, vendor, VI, Vitae, withdraw, withdrew, writ